Safety Data on Pfizer/BioNTech Vaccine Released by US

HBI Blog / Safety Data on Pfizer/BioNTech Vaccine Released by US

US regulators have recently confirmed that the Pfizer/BioNTech COVID vaccine is 95 percent effective, and have approved it for emergency use.

The FDA found no safety concerns that could hinder the approval of the BioNTech COVID vaccine and met on Thursday, December 10th, 2020 to make a formal decision. They have already published a document stating the trial data were “consistent”.

Pfizer Vaccine

Although two doses of the vaccine are required for complete protection against COVID-19, the first jab has been capable of preventing 89 percent of the severe cases.

Moreover, the vaccine also offers the same protection to people who had already had a COVID infection.

People, who have received the vaccine, have reported mild pain, redness, and swelling at the injection site to be the most common side effects. Often, it is followed by short-term fatigue, muscle pain, and headache.

Leave a Reply

Your email address will not be published.